C-peptide has been reported to prevent ocular vascular dysfunction in rats with diabetes of 5 weeks duration. This study was undertaken to compare effects of C-peptide alone, low dose insulin alone, and the combined treatments in reversing vascular dysfunction after 2 months of untreated diabetes. Male Sprague Dawley rats 270-300 g bw were made diabetic by i.v. injection of 50 mg/kg streptozotocin. Non-diabetic control received only buffer. After 2 months of diabetes, rats were randomly assigned to 4 groups (n=10 each) untreated diabetes (D), synthetic C-peptide (DC), insulin (DI) and C-peptide+insulin treatment (DCI). 400 ug/kg bw of human C-peptide was injected s.c. twice a day, and 10 U/kg bw of NPH insulin was injected once a day. One month later albumin permeation was assessed by using 125I- and 131I-albumin and blood flow was assessed by using 46Sc-microspheres. Body weight was increased by insulin, but not by C-peptide alone. Neither C-peptide nor insulin improved plasma glucose or glycated Hb. Diabetes increased albumin permeation in retina, anterior uvea and posterior uvea. Insulin or C-peptide alone did not affect albumin permeation. C-peptide+insulin decreased albumin permeation in retina, anterior uvea, and posterior uvea. Blood flows in D did not differ from controls, and were unaffected by C-peptide or insulin. Neither low dose insulin nor C-peptide alone were as effective as the combination in reversing diabetes-induced vascular dysfunction. These observations suggest a new use for C-peptide in the treatment of diabetic retinopathy.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
5P41RR000954-20
Application #
5221880
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
20
Fiscal Year
1996
Total Cost
Indirect Cost
Yue, Xuyi; Dhavale, Dhruva D; Li, Junfeng et al. (2018) Design, synthesis, and in vitro evaluation of quinolinyl analogues for ?-synuclein aggregation. Bioorg Med Chem Lett 28:1011-1019
Ohlemacher, Shannon I; Giblin, Daryl E; d'Avignon, D André et al. (2017) Enterobacteria secrete an inhibitor of Pseudomonas virulence during clinical bacteriuria. J Clin Invest 127:4018-4030
Lin, Xiaobo; Racette, Susan B; Ma, Lina et al. (2017) Endogenous Cholesterol Excretion Is Negatively Associated With Carotid Intima-Media Thickness in Humans. Arterioscler Thromb Vasc Biol 37:2364-2369
Ovod, Vitaliy; Ramsey, Kara N; Mawuenyega, Kwasi G et al. (2017) Amyloid ? concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimers Dement 13:841-849
Cade, W Todd; Levy, Philip T; Tinius, Rachel A et al. (2017) Markers of maternal and infant metabolism are associated with ventricular dysfunction in infants of obese women with type 2 diabetes. Pediatr Res 82:768-775
Lucey, Brendan P; Mawuenyega, Kwasi G; Patterson, Bruce W et al. (2017) Associations Between ?-Amyloid Kinetics and the ?-Amyloid Diurnal Pattern in the Central Nervous System. JAMA Neurol 74:207-215
Wei, Xiaochao; Song, Haowei; Yin, Li et al. (2016) Fatty acid synthesis configures the plasma membrane for inflammation in diabetes. Nature 539:294-298
Shields-Cutler, Robin R; Crowley, Jan R; Miller, Connelly D et al. (2016) Human Metabolome-derived Cofactors Are Required for the Antibacterial Activity of Siderocalin in Urine. J Biol Chem 291:25901-25910
Mertins, Philipp; Mani, D R; Ruggles, Kelly V et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534:55-62
Murata, Takahiro; Dietrich, Hans H; Horiuchi, Tetsuyoshi et al. (2016) Mechanisms of magnesium-induced vasodilation in cerebral penetrating arterioles. Neurosci Res 107:57-62

Showing the most recent 10 out of 696 publications